Bolt Biotherapeutics, Inc. (BOLT)

NASDAQ

$4,28

$--

(0,00%)

Pre-Market

Bolt Biotherapeutics, Inc. (BOLT) Live Price Chart

Last updated: ⁦2026-10-13 12:00:01⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Bolt Biotherapeutics, Inc. (BOLT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4,28, with a market capitalization of $7,92M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3,10 to $7,20. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$7,92M
Open	$4,28
Day's High	$861,40
Day's Low	$3,10
Previous Close	$4,24
Volume	10,00
Average Volume	27,52K
P/E Ratio	--
52-Week High	$7,20
52-Week Low	$3,10
Dividend Yield	--
Earnings Date	--

Bolt Biotherapeutics, Inc. (BOLT) Pre-Market Stock Price

Bolt Biotherapeutics, Inc. (BOLT) is trading at $4,28 in pre-market trading as of 2026-10-13 09:20:00, up 0,83% ($0,04) from the previous close of $4,24

Pre-market trading shows how investors are pricing BOLT before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Bolt Biotherapeutics, Inc. (BOLT) 7-Day Stock Price Change

Over the past seven days, Bolt Biotherapeutics, Inc. (BOLT) moved from $3,45 to $4,28, representing a gain of 23,91% ($0,83).

The stock traded between $3,38 and $4,68 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 30,62 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

BOLT 52-Week Price Position

Position in Range: 28,7%

52W Low$3,10

52W High$7,20

BOLT is currently trading at $4,28, placing it 28,7% of the way from its 52-week low of $3,10 to its 52-week high of $7,20. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Bolt Biotherapeutics, Inc. (BOLT)?

Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs include CEA ISAC program a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5, or CEA; PD-L1 ISAC utilizes a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker; and BDC-3042, its dectin-2 agonist antibody program, developed to repolarize critical cells in the tumor microenvironment known as tumor associated macrophages. It operates in single segment.

Bolt Biotherapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	23
Exchange	NASDAQ
Company Website	https://www.boltbio.com

How to Buy Bolt Biotherapeutics, Inc. (BOLT) Stock on MEXC

Eligible investors can buy real shares of Bolt Biotherapeutics, Inc. (BOLT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BOLT and Place Your Order

Open the RealStocks trading page and search for BOLT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Bolt Biotherapeutics, Inc. (BOLT) stock price today?

Bolt Biotherapeutics, Inc. (BOLT) is currently trading at $ 4,28, up 0,83% ($0,04) from the previous close of $ 4,24. Intraday prices update in real time during regular trading hours.

2.Is BOLT stock going up or down today?

As of 2026-10-13 09:20:00, BOLT is trading at $ 4,28, up 0,83% ($0,04) from its previous close of $ 4,24. The stock has traded between $ 3,10 and $ 861,40 during today’s regular session. Past price movements do not guarantee future results.

3.What is BOLT pre-market price?

As of 2026-10-13 09:20:00, BOLT is trading at $ 4,28 in pre-market trading, up 0,83% ($0,04) from the previous close of $ 4,24. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BOLT after-hours price?

As of 2026-10-13 09:20:00, BOLT is trading at $ 4,28 in after-hours trading, up 0,83% ($0,04) from the regular-session close of $ 4,24. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BOLT stock trading now?

BOLT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BOLT sit relative to its 52-week high and low?

Over the past 52 weeks, BOLT has traded between a low of $ 3,10 and a high of $ 7,20. At $ 4,28, the stock is positioned 28,7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Bolt Biotherapeutics, Inc. in?

Bolt Biotherapeutics, Inc. (BOLT) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Bolt Biotherapeutics, Inc.'s market capitalization and where is it listed?

Bolt Biotherapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 7,92M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BOLT valued in terms of P/E ratio and EPS?

BOLT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -14,92. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Bolt Biotherapeutics, Inc. pay a dividend?

Bolt Biotherapeutics, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.